dalteparin has been researched along with Bronchospasm, Exercise-Induced in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, T | 1 |
| Gonzalez, BJ | 1 |
| Danta, I | 1 |
1 trial available for dalteparin and Bronchospasm, Exercise-Induced
| Article | Year |
|---|---|
Prevention of exercise-induced bronchoconstriction by inhaled low-molecular-weight heparin.
Topics: Administration, Inhalation; Adolescent; Airway Resistance; Asthma, Exercise-Induced; Bronchial Provo | 1999 |